Reditux 100mg

Reditux 100mg is a medication used to treat certain types of cancer, including non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and rheumatoid arthritis. It is a solution for injection that works by targeting and destroying certain types of B cells in the body.

Composition:

Reditux 100mg contains Rituximab, a medication that is a monoclonal antibody.

Indications:

Reditux 100mg is indicated for the treatment of:

1. Non-Hodgkin’s lymphoma (NHL) in combination with chemotherapy
2. Chronic lymphocytic leukemia (CLL) in combination with chemotherapy
3. Rheumatoid arthritis (RA) in combination with methotrexate

Mechanism of Action:

Rituximab works by:

1. Targeting and binding to specific antigens on the surface of B cells
2. Marking these B cells for destruction by the immune system
3. Reducing the production of inflammatory cytokines

Dosage and Administration:

The recommended dosage of Reditux 100mg is:

• 100mg administered as an intravenous infusion over 30-60 minutes, every 8 weeks
• The dose should be adjusted based on the patient’s response to treatment and tolerability

Side Effects:

Common side effects of Reditux 100mg include:

1. Infusion-related reactions
2. Fatigue
3. Nausea and vomiting
4. Headache
5. Dizziness
6. Skin rash
7. Infections

Serious side effects can include:

1. Neutropenia (low white blood cell count)
2. Thrombocytopenia (low platelet count)
3. Anemia (low red blood cell count)
4. Hematologic toxicity (toxicity to the blood cells)
5. Increased risk of infections

Contraindications:

Reditux 100mg is contraindicated in patients with:

1. Hypersensitivity to Rituximab or other murine proteins
2. Severe allergic reactions to human serum albumin or other components of the medication

Precautions:

1. Patients with a history of cardiac disease should be closely monitored while receiving Reditux 100mg.
2. Patients with a history of kidney disease should be closely monitored while receiving Reditux 100mg.
3. Patients with a history of hepatitis B should be closely monitored while receiving Reditux 100mg.

Patient Counseling:

• Patients should be counseled on the importance of taking their medication as directed and not missing doses.
• Patients should be instructed to report any signs of infusion-related reactions or allergic reactions.
• Patients should be advised to report any changes in their appetite or weight loss.

Storage and Handling:

• Store at 2°C to 8°C (36°F to 46°F) in original packaging.
• Do not freeze or expose to direct sunlight.
• Use within 24 hours of opening.

Please note that the dosage and administration information is based on the recommended dosage and may vary depending on individual patient needs and circumstances.

As with any medication, it is important to consult with a healthcare professional before taking Reditux 100mg, especially if you have a history of medical conditions, are taking other medications, or are pregnant or breastfeeding.